Nagai M - Search Results

1

PICALM mRNA Expression in the Blood of Patients with Neurodegenerative Diseases and Geriatric Depression.

Kumon H, Yoshino Y, Funahashi Y, Mori H, Ueno M, Ozaki Y, Yamazaki K, Ochi S, Mori T, Iga JI, Nagai M, Nomoto M, Ueno SI. Kumon H, et al. Among authors: nagai m. J Alzheimers Dis. 2021;79(3):1055-1062. doi: 10.3233/JAD-201046. J Alzheimers Dis. 2021. PMID: 33386803 Free PMC article.

2

Pharmacokinetics of L-dopa in plasma and extracellular fluid of striatum in common marmosets.

Zhang J, Qu FR, Nakatsuka A, Nomura T, Nagai M, Nomoto M. Zhang J, et al. Among authors: nagai m. Brain Res. 2003 Dec 12;993(1-2):54-8. doi: 10.1016/j.brainres.2003.08.065. Brain Res. 2003. PMID: 14642830

3

[Neuropsychiatric complications associated with digestive system agents].

Nagai M, Nomoto M. Nagai M, et al. Nihon Rinsho. 2004 Jan;62 Suppl:498-502. Nihon Rinsho. 2004. PMID: 15011414 Review. Japanese. No abstract available.

4

Proteasome function and pathological proteins in the pathogenesis of Parkinson's disease.

Nomoto M, Nagai M. Nomoto M, et al. Among authors: nagai m. J Pharmacol Sci. 2005 Mar;97(3):455-6. doi: 10.1254/jphs.ltj05002x. Epub 2005 Mar 17. J Pharmacol Sci. 2005. PMID: 15781988 Free article. No abstract available.

5

Effect of clarithromycin on the pharmacokinetics of cabergoline in healthy controls and in patients with Parkinson's disease.

Nakatsuka A, Nagai M, Yabe H, Nishikawa N, Nomura T, Moritoyo H, Moritoyo T, Nomoto M. Nakatsuka A, et al. Among authors: nagai m. J Pharmacol Sci. 2006 Jan;100(1):59-64. doi: 10.1254/jphs.fp0050711. Epub 2006 Jan 13. J Pharmacol Sci. 2006. PMID: 16410677 Free article. Clinical Trial.

6

[Inter- and intraindividual pharmacokinetic variations in the treatment of Parkinson's disease].

Nomoto M, Nakatsuka A, Nagai M, Yabe H, Moritoyo T, Moritoyo H, Nisikawa N. Nomoto M, et al. Among authors: nagai m. Rinsho Shinkeigaku. 2005 Nov;45(11):895-8. Rinsho Shinkeigaku. 2005. PMID: 16447756 Japanese.

7

Plasma amantadine concentrations in patients with Parkinson's disease.

Nishikawa N, Nagai M, Moritoyo T, Yabe H, Nomoto M. Nishikawa N, et al. Among authors: nagai m. Parkinsonism Relat Disord. 2009 Jun;15(5):351-3. doi: 10.1016/j.parkreldis.2008.08.005. Epub 2008 Sep 27. Parkinsonism Relat Disord. 2009. PMID: 18823813

8

Inter- and intra-individual variation in L-dopa pharmacokinetics in the treatment of Parkinson's disease.

Nomoto M, Nishikawa N, Nagai M, Yabe H, Nakatsuka A, Moritoyo H, Moritoyo T, Kubo M. Nomoto M, et al. Among authors: nagai m. Parkinsonism Relat Disord. 2009 Jan;15 Suppl 1:S21-4. doi: 10.1016/S1353-8020(09)70007-0. Parkinsonism Relat Disord. 2009. PMID: 19131037 Review.

9

Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP.

Yabe H, Choudhury ME, Kubo M, Nishikawa N, Nagai M, Nomoto M. Yabe H, et al. Among authors: nagai m. J Pharmacol Sci. 2009 May;110(1):64-8. doi: 10.1254/jphs.09019fp. Epub 2009 Apr 29. J Pharmacol Sci. 2009. PMID: 19403994 Free article.

10

Fluctuation in plasma entacapone concentrations in accordance with variable plasma levodopa concentrations.

Nagai M, Kubo M, Nishikawa N, Nomoto M. Nagai M, et al. Parkinsonism Relat Disord. 2010 Dec;16(10):697-9. doi: 10.1016/j.parkreldis.2010.08.019. Epub 2010 Sep 19. Parkinsonism Relat Disord. 2010. PMID: 20855228 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,227 results

Search Page

Filters